Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T14:09:42.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website changes and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.4%
    Check dated 2026-10-24T13:30:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:31:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T14:31:27.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The history now shows a new page revision (v3.7.0) added and the previous revision (v3.6.6) removed, indicating a UI/system update to the page without altering the study details.
    Difference
    0.1%
    Check dated 2026-09-19T20:53:06.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new history entry (version 51) dated 2026-09-02 was added with a Study Status update. An entry dated 2026-06-23 was removed from the history.
    Difference
    0.2%
    Check dated 2026-09-05T18:52:28.000Z thumbnail image

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.